Invivo colonization pro¢le study ofBordetellabronchiseptica in the nasal cavity
暂无分享,去创建一个
[1] A. Abe,et al. BopC Is a Novel Type III Effector Secreted by Bordetella bronchiseptica and Has a Critical Role in Type III-dependent Necrotic Cell Death* , 2006, Journal of Biological Chemistry.
[2] D. Relman,et al. Species- and Strain-Specific Control of a Complex, Flexible Regulon by Bordetella BvgAS , 2006, Journal of bacteriology.
[3] P. Šebo,et al. Bordetella adenylate cyclase toxin: a swift saboteur of host defense. , 2006, Current opinion in microbiology.
[4] Seema Mattoo,et al. A genome‐wide screen identifies a Bordetella type III secretion effector and candidate effectors in other species , 2005, Molecular microbiology.
[5] O. Bjørnstad,et al. Evolution and emergence of Bordetella in humans. , 2005, Trends in microbiology.
[6] S. Boitano,et al. Bordetella bronchiseptica Adherence to Cilia Is Mediated by Multiple Adhesin Factors and Blocked by Surfactant Protein A , 2005, Infection and Immunity.
[7] Seema Mattoo,et al. Molecular Pathogenesis, Epidemiology, and Clinical Manifestations of Respiratory Infections Due to Bordetella pertussis and Other Bordetella Subspecies , 2005, Clinical Microbiology Reviews.
[8] P. Cotter,et al. BvgA functions as both an activator and a repressor to control Bvgi phase expression of bipA in Bordetella pertussis , 2005, Molecular microbiology.
[9] Nuria Vergara-Irigaray,et al. Evaluation of the Role of the Bvg Intermediate Phase in Bordetella pertussis during Experimental Respiratory Infection , 2005, Infection and Immunity.
[10] Jason A. Skinner,et al. Downregulation of Mitogen-Activated Protein Kinases by the Bordetella bronchiseptica Type III Secretion System Leads to Attenuated Nonclassical Macrophage Activation , 2005, Infection and Immunity.
[11] Yasuhiko Irie,et al. The Bvg Virulence Control System Regulates Biofilm Formation in Bordetella bronchiseptica , 2004, Journal of bacteriology.
[12] Jason A. Skinner,et al. Bordetella Type III Secretion and Adenylate Cyclase Toxin Synergize to Drive Dendritic Cells into a Semimature State1 , 2004, The Journal of Immunology.
[13] Allison M. Jones,et al. Phosphorelay control of virulence gene expression in Bordetella. , 2003, Trends in microbiology.
[14] C. Guzmán,et al. The virulence factors of Bordetella pertussis: a matter of control. , 2001, FEMS microbiology reviews.
[15] Jeff F. Miller,et al. Identification and characterization of BipA, a Bordetella Bvg‐intermediate phase protein , 2001, Molecular microbiology.
[16] Jeff F. Miller,et al. Modulation of host immune responses, induction of apoptosis and inhibition of NF‐κB activation by the Bordetella type III secretion system , 2000, Molecular microbiology.
[17] Jeff F. Miller,et al. Probing the Function of Bordetella bronchiseptica Adenylate Cyclase Toxin by Manipulating Host Immunity , 1999, Infection and Immunity.
[18] D. Relman,et al. Filamentous Hemagglutinin of Bordetella bronchiseptica Is Required for Efficient Establishment of Tracheal Colonization , 1998, Infection and Immunity.
[19] M. Ackermann,et al. A highly adherent phenotype associated with virulent Bvg+-phase swine isolates of Bordetella bronchiseptica grown under modulating conditions , 1997, Infection and immunity.
[20] Jeff F. Miller,et al. A mutation in the Bordetella bronchiseptica bvgS gene results in reduced virulence and increased resistance to starvation, and identifies a new class of Bvg‐regulated antigens , 1997, Molecular microbiology.
[21] Jeff F. Miller,et al. Ectopic expression of the flagellar regulon alters development of the bordetella-host interaction , 1995, Cell.
[22] D. Relman,et al. Bordetella pertussis filamentous hemagglutinin interacts with a leukocyte signal transduction complex and stimulates bacterial adherence to monocyte CR3 (CD11b/CD18) , 1994, The Journal of experimental medicine.
[23] J. Miller,et al. BvgAS-mediated signal transduction: analysis of phase-locked regulatory mutants of Bordetella bronchiseptica in a rabbit model , 1994, Infection and immunity.
[24] E. Tuomanen,et al. Identification of a carbohydrate recognition domain in filamentous hemagglutinin from Bordetella pertussis , 1993, Infection and immunity.
[25] F. Merkus,et al. The Nasal Mucociliary Clearance: Relevance to Nasal Drug Delivery , 1991, Pharmaceutical Research.
[26] C. Cabellos,et al. Integrin-mediated localization of Bordetella pertussis within macrophages: role in pulmonary colonization , 1991, The Journal of experimental medicine.
[27] G. Flynn,et al. Absorption of Polyethylene Glycols 600 Through 2000: The Molecular Weight Dependence of Gastrointestinal and Nasal Absorption , 1990, Pharmaceutical Research.
[28] D. Relman,et al. Recognition of a bacterial adhesin by an integrin: Macrophage CR3 (α M β 2, CD11b CD18 ) binds filamentous hemagglutinin of Bordetella pertussis , 1990, Cell.
[29] R. Maronpot,et al. Normal histology of the nasal cavity and application of special techniques. , 1990, Environmental health perspectives.
[30] J P Jacky,et al. Barometric measurement of tidal volume: effects of pattern and nasal temperature. , 1980, Journal of applied physiology: respiratory, environmental and exercise physiology.
[31] D W Stainer,et al. A simple chemically defined medium for the production of phase I Bordetella pertussis. , 1970, Journal of general microbiology.
[32] Paul Stoodley,et al. Biofilm formation and dispersal and the transmission of human pathogens. , 2005, Trends in microbiology.
[33] D. Relman,et al. Recognition of a bacterial adhesion by an integrin: macrophage CR3 (alpha M beta 2, CD11b/CD18) binds filamentous hemagglutinin of Bordetella pertussis. , 1990, Cell.